Retatrutide is a novel triagonist peptide that simultaneously targets three critical metabolic receptors: Glucagon-like peptide-1 (GLP-1) Glucose-dependent insulinotropic polypeptide (GIP) Glucagon Originally developed for clinical research into obesity and metabolic disorders, retatrutide is designed to support extensive scientific exploration of: Weight reduction Improved glucose management Enhanced metabolic function What Key Benefits Does Retatrutide Offer
RetaLABS stocks research-grade reta peptide (retatrutide) in 10mg, 20mg, and 30mg vials for laboratory research use only
User further understands and agrees that the Company reserves the right to update, change, alter, or modify its Website, which may cause delay or unavailability
Whether youre struggling with weight, body image, or co-occurring mental health conditions, safe, supervised care is the best path forward
Mounjaro met tirzepatide is het enige beschikbare medicijn dat op beide hormonen tegelijk werkt